Caidya Announces Strategic Combination with Simbec-Orion — Learn more here

+44 (0) 1753 578 080

[email protected]

KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results

Back to Clinical Trial Publications Archive
Blood tests are used in lab tests to detect and quantify a substance

 KalVista Pharmaceuticals partnered with Simbec-Orion to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of KVD900, an orally administered inhibitor of PKa in healthy adults.

Read the full paper

Back to Clinical Trial Publications Archive